Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

By KATRINA BRANDON DONATIONS have opened up opportunities at Latrobe Regional Hospital (LRH) thanks to Latrobe's Biggest Ever ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

Learn about prostate cancer, its diagnosis, treatment options, and the latest study findings. Understand which types need ...

As men get older, cancer rates increase throughout the body. We look for more options for treatment, in Prescription: Health.

For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have been taking oral supplements of biotin, which are marketed to consumers for ...

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies' registrational ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...